How effective is plasmapheresis compared to IVIG in treating Guillain-Barré syndrome?

22 October 2026Original research1 min read

By Tripdatabase.

Abstract

Both IVIG and plasmapheresis are effective for treating Guillain-Barré syndrome with similar long-term outcomes, though IVIG may be preferred due to its ease of administration and lower discontinuation risk.

Keywords

Peripheral Neuropathies and Disorders
Guillain-Barré syndrome
plasmapheresis

Read around a topic while you study.

Ward brings these articles into the same app as your cards and questions. One free account for Ward, Suture, Osler and Prognia.

Discover Ward

intravenous immunoglobulin

treatment efficacy

long-term outcomes

immunotherapy

Open access

Authors

Tripdatabase

Source

Published in Zenodo (CERN European Organization for Nuclear Research). The abstract is shown as published and remains the work of its authors; read the full article at the source.

doi.org/10.5281/zenodo.23554723

Prognia lists this article for reference and education. It is not medical advice. Always read the original and follow current guidelines and local protocols before acting on it.

At a glance

Journal: Zenodo
Type: Original research
Published: 22 October 2026
Specialty: Neurology
Read time: 1 min
Authors: 1
DOI: 10.5281/zenodo.23554723